الصفحة الرئيسية>>Signaling Pathways>> PROTAC>> PROTAC>>PROTAC-O4I2

PROTAC-O4I2

رقم الكتالوجGC63916

PROTAC-O4I2 هو عامل ربط أهداف PROTAC 3B1 (SF3B1)يؤدي PROTAC-O4I2 إلى تدهور FLAG-SF3B1 بقيمة IC50 تبلغ 0.244 ميكرومتر في خلايا K562يحفز PROTAC-O4I2 أيضًا موت الخلايا المبرمج الخلوي في خلايا K562 WT

Products are for research use only. Not for human use. We do not sell to patients.

PROTAC-O4I2 التركيب الكيميائي

الحجم السعر المخزون الكميّة
5 mg
144٫00
متوفر
10 mg
225٫00
متوفر
25 mg
495٫00
متوفر
50 mg
855٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

PROTAC-O4I2 is a PROTAC targets splicing factor 3B1 (SF3B1). PROTAC-O4I2 induces FLAG-SF3B1 degradation with an IC50 value of 0.244 μM in K562 cells. PROTAC-O4I2 also induces cellular apoptosis in K562 WT cells[1].

PROTAC-O4I2 introduces Thalidomide to ubiquitin E3 ligase cereblon (CRBN), which selectively degrades SF3B1 and inhibits tumor growth in cells[1].PROTAC-O4I2 degrades and inhibits SF3B1 in K562 cells. PROTAC-O4I2 exhibits anti-proliferation effects on SF3B1 WT, SF3B1 OE, and SF3B1 K700E cells with IC50s of 228, 63, and 90 nM, respectively[1].PROTAC-O4I2 induces FLAG-SF3B1 degradation in a concentration-dependent manner with a half maximal inhibitory concentration (IC50) value of 0.244 μM in K562 cells[1].

PROTAC-O4I2 significantly increases survival by interference with the maintenance and proliferation of tumor in a Drosophila intestinal tumor model[1].

[1]. Rodrigo A Gama-Brambila, et al. A PROTAC targets splicing factor 3B1. Cell Chem Biol. 2021 Nov 18;28(11):1616-1627.e8.

مراجعات

Review for PROTAC-O4I2

Average Rating: 5 ★★★★★ (Based on Reviews and 21 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for PROTAC-O4I2

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.